Influenza Vaccines

Recent News

Apr 30, 2021

News Scan for Apr 30, 2021

Maternal COVID and infant outcomes
Nasopharyngeal swab complications
Flu vaccine nudges
Polio in 9 countries
Feb 26, 2021

News Scan for Feb 26, 2021

Northern Hemisphere flu vaccine strains
Details on Russian H5N8 flu cases
Polio cases in 6 nations
Feb 10, 2021

News Scan for Feb 10, 2021

Telehealth antibiotic stewardship
Macrolide-resistant strep
MERS in Saudi Arabia
Intradermal flu vaccines
Jan 19, 2021
Influenza researcher

Flu vaccine roadmap aims to promote game-changers, equity

Truly revolutionary flu vaccines and equitable distribution are key goals.

Jan 19, 2021
Globe and astronomical clock

COMMENTARY: From hope to reality: The promise of the Influenza Vaccines R&D Roadmap

Overcoming obstacles to better flu vaccines requires collaboration through innovative approaches on a broad scale.

Jan 19, 2021

News Scan for Jan 19, 2021

Coronavirus in ICE facilities
Kids and COVID spread
Waning flu vaccine efficacy
H5N1 and H5N8 avian flu
Jan 15, 2021

News Scan for Jan 15, 2021

COVID-19 in pregnant women
COVID immunity & disease spread
High-dose flu vaccine safety
H5N6, H9N2 flu cases in China
Polio in 3 countries
Jan 06, 2021

News Scan for Jan 06, 2021

Incentives for new antibiotics
Cell-derived flu vaccine protection
Flu vaccine in nursing homes
Dec 28, 2020

Flu Scan for Dec 28, 2020

Flu vaccine effectiveness
Avian flu outbreaks overseas
Dec 11, 2020
Older man getting the flu vaccine

Experts: Despite study findings, at-risk patients need high-dose flu vaccine

A large body of data shows the high-dose vaccine yields greater protection than standard-dose vaccines.

Resources & Literature

Recent Literature

Bardenheier BH, Baier RP, Silva JB, et al. Persistence of racial inequities in receipt of influenza vaccination among nursing home residents in the United States. Clin Infect Dis 2020 (published online Sep 29)

Benjamin-Chung J, Arnold BF, Kennedy CJ, et al. Evaluation of a city-wide school-located influenza vaccination program in Oakland, California, with respect to vaccination coverage, school absences, and laboratory-confirmed influenza: a matched cohort study. PLoS Med 2020 (published online Aug 18)

Beran J, Reynales H, Poder A, et al. Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study. Lancet Infect Dis 2021 (published online Feb 9)

Bettinger JA, De Serres G, Valiquette L, et al. 2017/18 and 2018/19 seasonal influenza vaccine safety surveillance, Canadian National Vaccine Safety (CANVAS) Network. Euro Surveill 2020 Jun 4;25(22)

Boddington NL, Pearson I, Whitaker H, et al. Effectiveness of influenza vaccination in preventing hospitalisation due to influenza in children: a systematic review and meta-analysis. Clin Infect Dis 2021 (published online Mar 28)

Boikos C, Fischer L, O'Brien D, et al. Relative effectiveness of adjuvanted trivalent inactivated influenza vaccine versus egg-derived quadrivalent inactivated influenza vaccines and high-dose trivalent influenza vaccine in preventing influenza-related medical encounters in US adults ≥65 years during the 2017-2018 and 2018-2019 influenza seasons. Clin Infect Dis 2021 (published online Feb 19)

Boikos C, Fischer L, O'Brien D, et al. Relative effectiveness of the cell-derived inactivated quadrivalent influenza vaccine versus egg-derived inactivated quadrivalent influenza vaccines in preventing influenza-related medical encounters during the 2018-2019 influenza season in the United States. Clin Infect Dis 2021 (published online Jan 5)

Boikos C, Imran M, Nguyen VH, et al. Effectiveness of the cell-derived inactivated quadrivalent influenza vaccine in individuals at high risk of influenza complications in the 2018-2019 US influenza season. Open Forum Infect Dis 2021 (published online Apr 2)

Bonnevie E, Rosenberg SD, Kummeth C, et al. Using social media influencers to increase knowledge and positive attitudes toward the flu vaccine. PLoS One 2020 (published online Oct 16)

Campbell AP, Ogokeh C, Lively JY, et al. Vaccine effectiveness against pediatric influenza hospitalizations and emergency visits. Pediatrics 2020 Oct:e20201368

Carnahan A, Perez JJ, Robertson AH, et al, for the EU/EEA NITAG. Systematic review of the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals aged 18 years and over. ECDC 2020 Oct

Carrera M, Lawler E, White C. Population mortality and laws encouraging influenza vaccination for hospital workers. Ann Intern Med 2021 (published online Jan 5)

Chan MS, Jamieson KJ, Albarracin D. Prospective associations of regional social media messages with attitudes and actual vaccination: a big data and survey study of the influenza vaccine in the United States. Vaccine 2020 (published online Aug 11)

Chang A, Ellingson MK, Flowers CR, et al. Influenza vaccination rates among patients with a history of cancer: analysis of the National Health Interview Survey. Open Forum Infect Dis 2021 (published online Apr 20)

Chen D, Ye Z, Pi Z, et al. Cost-effectiveness of dual influenza and pneumococcal vaccination among the elderly in Shenzhen, China. Vaccine 2021 (published online Mar 20)

Chiu SS, Chua H, Kwan MY, et al. Influenza vaccination effectiveness in preventing influenza hospitalization in children, Hong Kong, winter 2019/20. Vaccine 2020 (published online Nov 6)

Choi EJ, Park JH, Chun BC. Cost effectiveness of trivalent and quadrivalent influenza vaccines in 50- to 64-year-old adults in Korea. Vaccine 2020 (published online Jun 10)

Chow EJ, Rolfes MA, Carrico RL, et al. Vaccine effectiveness against influenza-associated lower respiratory tract infections in hospitalized adults, Louisville, Kentucky, 2010-2013. Open Forum Infect Dis 2020 (published online Jun 30)

Chung H, Buchan SA, Campigotto A, et al. Influenza vaccine effectiveness against all-cause mortality following laboratory-confirmed influenza in older adults, 2010-2011 to 2015-2016 seasons in Ontario, Canada. Clin Infect Dis 2020 (published online Dec 23)

Colrat F, Thommes E, Largeron N, et al. Economic evaluation of high-dose inactivated influenza vaccine in adults aged ≥65 years: a systematic literature review. Vaccine 2021 (published online Jan 29)

Conlon A, Ashur C, Washer L, et al. Impact of the influenza vaccine on COVID-19 infection rates and severity. 2021 Am J Infect Control (published online Feb 22)

Cowling BJ, Thompson MG, Ng TW, et al. Comparative reactogenicity of enhanced influenza vaccines in older adults. J Infect Dis 2020 (published online May 14)

Darricarrere N, Qiu Y, Kanekiyo M, et al. Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates. Sci Transl Med 2021 Mar 3;13(583)

De Figueiredo A, Simas C, Karafillakis E, et al. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. Lancet 2020 (published online Sep 10)

Drori Y, Pando R, Sefty H, et al. Influenza vaccine effectiveness against laboratory-confirmed influenza in a vaccine-mismatched influenza B-dominant season. Vaccine 2020 (published online Nov 23)

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson FoundationUnorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead Become an underwriter»